Mice were subcutaneously injected with equivalent doses of aM-exos and aMT-exos (30 μg, 3.69×109 particles). 3 days later, the LNs were removed from mice and prepared to single cell suspension. Then, CD8 T cells were sorted out using CD8 Dynabeads and used for RNA isolation. RNA samples were analyzed by High-throughput sequencing of TRB using the ImmuHubTCR profiling system (ImmuQuad Biotech). Briefly, a 5’ RACE unbiased amplification protocol was used. This protocol uses unique molecular barcodes introduced in the course of cDNA synthesis to control bottlenecks and to eliminate PCR and sequencing errors. Sequencing was performed on an Illumina NovSeq® system with PE150 mode (Illumina). One common adaptor with UMB was added on the 5’of cDNA during the first-strand cDNA synthesize and one reverse primer corresponding to the constant (C) regions of each of the TRB were designed to facilitate PCR amplification of cDNA sequences in a less biased manner. The UMB attached to each raw sequence reads were applied to correct PCR and sequencing errors correction and PCR duplicates removing. Map V, D, J and C segments with IMGT® and then extract CDR3 regions and assemble clonotype for all clones. The resulting nucleotide and amino acid sequences of CDR3 of TRB were determined and those with out-of-frame and stop codon sequences were removed from the identified TRB repertoire. We further defined amounts of each TRB clonotype by adding numbers of TRB clones sharing the same nucleotide sequence of CDR3.
Copyright: Content may be subjected to copyright.
How to cite:
Readers should cite both the Bio-protocol preprint and the original research article where this protocol was used:
Wang, S, Wei, W and Ma, G(2022). T cell receptor beta chain (TRB) sequencing of CD8 T cells from LNs. Bio-protocol Preprint. bio-protocol.org/prep1876.
Wang, S., Li, F., Ye, T., Wang, J., Lyu, C., Qing, S., Ding, Z., Gao, X., Jia, R., Yu, D., Ren, J., Wei, W. and Ma, G.(2021). Macrophage-tumor chimeric exosomes accumulate in lymph node and tumor to activate the immune response and the tumor microenvironment. Science Translational Medicine 13(615). DOI: 10.1126/scitranslmed.abb6981
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this
article to respond.
0/150
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.
Spinning
Post a Question
0 Q&A
Spinning
This protocol preprint was submitted via the "Request
a Protocol" track.